【24h】

Moving towards fast characterization of polymorphic drugs by solid-state NMR spectroscopy

机译:通过固态NMR光谱朝向多态性药物的快速表征

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract Display Omitted Highlights ? Paramagnetic reagents were added to polymorphic drugs to decrease T 1 relaxation times. ? ICP-OES confirmed inverse relationship between concentration and T 1 relaxation time. ? SS-NMR and PXRD reveal that crystal structure is preserved after experimentation. ? Adding a paramagnetic agent does not alter the crystal structure nor transform the polymorph. ? Nickel and chromium ions have different effects on the T 1 relaxation times. Abstract Solid-state nuclear magnetic resonance (SS-NMR) spectroscopy has become a common technique to study polymorphism in pharmaceutical solids at high-resolution. However, high-throughput application of high resolution SS-NMR spectroscopy is severely limited by the long 1 H spin-lattice relaxation (T 1 ) that is common to solid phase compounds. Here, we demonstrate the use of paramagnetic relaxation reagents such as chromium (III) acetylacetonate (Cr(acac) 3 ) and nickel (II) acetylacetonate (Ni(acac) 2 ) for fast data acquisition by significantly reducing the T 1 value for carbamazepine Forms I, II, III, and dihydrate, cimetidine Forms A and B, nabumetone Form I, and acetaminophen Form I polymorphs. High resolution 13 C cross-polarization and magic angle spinning were used to measure T 1 values for each polymorph. In order to confirm the absence of polymorphic transitions during SS-NMR experiments, powder x-ray diffraction was implemented. The amount of chromium ions incorporated by the recrystallization process was quantified by using inductively coupled plasma optical emission spectroscopy. Our results suggest that the paramagnetic ions added to the polymorphs do not affect the polymorphic transformation or the quality of NMR spectra. We believe that this successful demonstration of fast data collection will enable high-throughput utilization of SS-NMR techniques to study polymorphic solids and could set the groundwork for NMR crystallography studies.
机译:图形抽象显示省略了亮点?将顺磁性试剂加入多态药物中以降低T 1弛豫时间。还是ICP-OES确认了浓度和T 1弛豫时间之间的逆关系。还是SS-NMR和PXRD显示在实验后保存晶体结构。还是添加顺磁性剂不会改变晶体结构,也不改变多晶型物。还是镍和铬离子对T 1弛豫时间有不同的影响。摘要固态核磁共振(SS-NMR)光谱经过高分辨率在药物固体中研究多态性的常用技术。然而,高分辨率SS-NMR光谱的高通量施用受到固相化合物共同的长1 H旋转晶格弛豫(T 1)的严重限制。在此,我们证明了使用顺磁性松弛试剂,例如铬(III)乙酰丙酮(Cr(ACAC)3)和乙酰丙酮(Ni(ACAC)2),以通过显着减少卡巴马嗪的T 1值来快速数据采集形式I,II,III和二水合物,Cimetidine形成A和B,Nabutone形式I和乙酰氨基酚形式I多晶型物。使用高分辨率13 C交叉极化和魔法角纺用于测量每个多晶型物的T 1值。为了确认在SS-NMR实验期间没有多态性转变,实施粉末X射线衍射。通过使用电感耦合的等离子体光发射光谱来定量通过再结晶过程的铬离子的量。我们的研究结果表明,添加到多晶型物中的顺磁离子不会影响多态转化或NMR光谱的质量。我们认为,这种快速数据收集的成功示范将实现SS-NMR技术的高通量利用,以研究多晶型固体,并可以设定NMR晶体学研究的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号